Health, Fitness & Food

Dr. Jordan Shlain, founder of Private Medical. Credit: Jordan Shlain A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. When people ask Dr. Jordan Shlain to describe his medical practice, he says

In this article MS NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNT A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023. Jeenah Moon | The Washington Post | Getty Images A highly popular group of weight loss and diabetes drugs is decreasing some consumers’ appetites — and

In this article UNH Follow your favorite stocksCREATE FREE ACCOUNT UnitedHealth Group reported better-than-expected revenue in its first-quarter results on Tuesday, though the company is still dealing with the fallout from the cyberattack on its subsidiary Change Healthcare. Here’s how the company did: Earnings: $6.91 per share adjusted, which may not compare with the $6.61

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Most doses of Eli Lilly‘s highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through

In this article ME Follow your favorite stocksCREATE FREE ACCOUNT Signage at 23andMe headquarters in Sunnyvale, California, U.S., on Wednesday, Jan. 27, 2021. David Paul Morris | Bloomberg | Getty Images 23andMe CEO Anne Wojcicki is considering a proposal to take the genetic testing company private after its stock price has tumbled more than 95%

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s most valuable health-care company even after it’s been crushing the S & P 500’s performance over the past three years. The study results released by Eli Lilly on Wednesday highlight the

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016. Revenue for the three months ended March 31 rose slightly more than 2% year over year to $9.96 billion,

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drug shortages in the U.S. are at a record high, leaving countless patients

In this article UNH Follow your favorite stocksCREATE FREE ACCOUNT Omar Marques | Lightrocket | Getty Images UnitedHealth Group’s first-quarter earnings report Tuesday will mark the health-care giant’s first major public comments since a cyberattack on its Change Healthcare billing and payments subsidiary in February, which has led to the largest disruption in U.S. health

Joos Mind | Photodisc | Getty Images Particle Health said on Monday that the “vast majority” of its customers are still receiving records from medical software giant Epic Systems despite an ongoing dispute between the two companies over data-sharing practices. Epic’s software supports more than 300 million patient records, and Particle acts like a middleman

The eponymous sign outside Epic headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC Epic Systems, the largest provider of software for managing medical records, says a venture-backed startup called Particle Health is using patient data in unauthorized and unethical ways that have nothing to do with treatment. Epic told customers in a notice on

In this article NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNT Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters European Union drug regulators found no evidence that highly popular weight loss and diabetes drugs such as Wegovy and Ozempic are linked

A probiotic culture experiment in a laboratory. Future Publishing | Future Publishing | Getty Images Seed Health has been in the business of microbiome scientific breakthroughs since its founding in 2015, but its biggest success to-date may have been becoming profitable as a bioscience startup. The popularity of the company’s original product, DS-01, a daily

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT A nurse prepares a dose of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on September 9, 2021. Patrick Meinhardt | AFP | Getty Images Moderna on Thursday said it has paused plans to build a vaccine-manufacturing site in Kenya after a steep drop

In this article GSK PFE Follow your favorite stocksCREATE FREE ACCOUNT Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late

Denver Beer Co. Courtesy: Denver Beer Co. This story is part of CNBC’s new quarterly Cities of Success series, which explores cities that have been transformed into business hubs with an entrepreneurial spirit that has attracted capital, companies and workers. Alcohol-free beverage options have skyrocketed over the past few years, and that trend has especially

In this article BMY JNJ Follow your favorite stocksCREATE FREE ACCOUNT Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Hi folks! Two competing cell therapies from Bristol Myers Squibb and Johnson & Johnson both got good news from

Thomas Kurian, CEO of Google Cloud, speaks at a cloud computing conference held by the company in 2019. Michael Short | Bloomberg | Getty Images Google Cloud and the German health-care company Bayer on Tuesday announced they are building an artificial intelligence-powered platform that aims to help radiologists diagnose patients and work through cases more